panCELLa

Canada · 9 Employees
Co-founded in 2015 by Dr. Andras Nagy, PhD, and Dr. Armand Keating, MD, PhD,. The expertise represented by the co-founders were a perfect combination to create a unique conceptual framework for a company aiming to move cell therapy to broad clinical applications. panCELLa has created platforms that allow for the development of safe, universal, cost-effective, "off-the-shelf" therapeutic cell products for medicine. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive FailSafe® and Stealth Cells®, and its in-licensed SAFE harbor technology. panCELLa continues its internal R&D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination and tolerization. In October 2022 Pluristyx announced a merger with panCELLa. PanCELLa today offers an array of unique and effective technologies with particular strength in gene editing, while Pluristyx offers a portfolio of induced Pluripotent Stem Cell (iPSC)-based products and services to provide end-to-end client support in early product development. As one company, panCELLa and Pluristyx offer an enlarged portfolio whose long-term focus is to become the global leader in clinical-grade, genetically modified, "off-the-shelf" iPSCs with the lowest barrier to entry for cell therapy development, providing clients with the fastest speed to clinic and the best route to commercialization.

概述

国家 Canada
成立时间 2015
总部 661 University Ave, Toronto, Ontario CA
电话号码 +1 888-613-6862
网站 http://www.pancella.com
LinkedIn http://www.linkedin.com/company/pancella
Twitter https://twitter.com/pancellainc
Facebook https://www.facebook.com/panCELLaInc
员工数 9
行业 research,
简介 Co-founded in 2015 by Dr. Andras Nagy, PhD, and Dr. Armand Keating, MD, PhD,. The expertise represented by the co-founders were a perfect combination to create a unique conceptual framework for a company aiming to move cell therapy to broad clinical applications. panCELLa has created platforms that allow for the development of safe, universal, cost-effective, "off-the-shelf" therapeutic cell products for medicine. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive FailSafe® and Stealth Cells®, and its in-licensed SAFE harbor technology. panCELLa continues its internal R&D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination and tolerization. In October 2022 Pluristyx announced a merger with panCELLa. PanCELLa today offers an array of unique and effective technologies with particular strength in gene editing, while Pluristyx offers a portfolio of induced Pluripotent Stem Cell (iPSC)-based products and services to provide end-to-end client support in early product development. As one company, panCELLa and Pluristyx offer an enlarged portfolio whose long-term focus is to become the global leader in clinical-grade, genetically modified, "off-the-shelf" iPSCs with the lowest barrier to entry for cell therapy development, providing clients with the fastest speed to clinic and the best route to commercialization.

技术

Gmail

Email Providers

Google Apps

Other

Mobile Friendly

Other

WordPress.org

CMS

常见问题

panCELLa 在哪里?

panCELLa 的总部位于 661 University Ave, Toronto, Ontario CA

panCELLa 的电话号码是多少?

panCELLa 的电话号码是 +1 888-613-6862

panCELLa 的官方网站是什么?

panCELLa 的公司官方网站是 http://www.pancella.com

panCELLa 是做什么的?

panCELLa 的业务有哪些?

regenerative medicine,stem cells,cell therapy

panCELLa 的年收入是多少?

panCELLa 的收入是 0美元

panCELLa 有多少员工?

panCELLa 有 9 名员工

panCELLa 属于哪个行业?

panCELLa 从事以下行业: research

panCELLa 使用什么技术?

panCELLa 使用的一些流行技术包括: Gmail,Google Apps,Mobile Friendly,WordPress.org

如何联系 panCELLa?

panCELLa 联系信息: 电话号码:+1 888-613-6862, 网站:http://www.pancella.com, 邮箱:gua***@***.com

panCELLa 的社交媒体链接是什么?

panCELLa 领英:http://www.linkedin.com/company/pancella,fackbook:https://www.facebook.com/panCELLaInc,twitte:https://twitter.com/pancellainc

panCELLa 是一家上市公司吗?

不是

panCELLa 的最后一轮融资是什么时候?

panCELLa在2018-01-24T00:00:00.000+00:00结束了最后一轮融资,金额达1M$。

谁投资 panCELLa?

panCELLa 有 1 家投资者,包括 Chiefswood Holdings Limited。

管理层

Guang Shi

Senior Scientist, Team Lead

Myia Turner

Manager of Operations

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google